TGF-β1 induces erlotinib resistance in non-small cell lung cancer by down-regulating PTEN

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Hua ShenYongqian Shu

Abstract

TKI-acquired resistance is a tough obstacle for effectively treating NSCLC patients with EGFR mutant characteristics. T790M mutations and MET amplifications account for 70% of the acquired resistance, but the causes for the remaining 30% need elucidation. We detected TGF-β1and PTEN expression levels in 51 NSCLC patients undergoing EGFR-TKI treatment using Immunohistochemistry (IHC) assay. We examined erlotinib sensitivity, apoptosis rate, and invasion ability in PC-9 cells and PC-9/TGF-β1 cells with CCK-8, flow cytometry, and trans-well assays. We examined and analyzed the AKT and ERK pathways' expression levels using western blot. High TGF-β1 and low PTEN expression levels were correlated with poor EGFR-TKI sensitivity and overall survival in 51 NSCLC samples. In vitro analysis revealed that TGF-β1 could reduce erlotinib sensitivity, increase anti-apoptosis ability and invasive characteristic in TKI-sensitive PC-9 cell lines by down-regulating PTEN and activating the Akt and ERK pathways. The results suggest that TGF-β1 demonstrated another acquired erlotinib resistance by down-regulating PTEN expression.

References

Jun 25, 1998·International Journal of Cancer. Journal International Du Cancer·C Asselin-PaturelF Mami-Chouaib
Dec 2, 2004·Nature Reviews. Drug Discovery·Jonathan M YinglingJ Scott Sawyer
Jul 9, 2005·International Journal of Cancer. Journal International Du Cancer·Maarten L JanmaatGiuseppe Giaccone
Aug 15, 2006·The Journal of Clinical Investigation·Jeffrey A EngelmanPasi A Jänne
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Jul 6, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Daniel B CostaMark S Huberman
Jun 24, 2008·The Journal of Clinical Investigation·Marta GuixJeffrey A Engelman
Sep 22, 2009·The Annals of Thoracic Surgery·Benjamin E LeeNasser Altorki
Dec 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tadaaki YamadaSeiji Yano
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Sep 23, 2010·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Hua ShenYong-Qian Shu
Nov 17, 2010·Proceedings of the National Academy of Sciences of the United States of America·Nicola ValeriCarlo M Croce
Jan 10, 2012·Molecular Cancer Therapeutics·Youngwook KimKeunchil Park
Feb 4, 2012·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Shen HuaShu Yongqian
Feb 10, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wei WangSeiji Yano
Aug 29, 2012·Molecular Cancer Therapeutics·Atul BediRajani Ravi
Mar 28, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Xiao-Hong KangMing-Juan Liao
Jun 26, 2013·AJR. American Journal of Roentgenology·Mizuki NishinoBruce E Johnson
Aug 6, 2013·Critical Reviews in Oncology/hematology·Jacques CadranelMarie Wislez
Aug 28, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Glenwood D GossFrances A Shepherd
Oct 8, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Rolf StahelAlex A Adjei
Nov 26, 2013·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hua ShenYongqian Shu

❮ Previous
Next ❯

Citations

Oct 27, 2017·Nature Reviews. Cancer·Julia Rotow, Trever G Bivona
Mar 9, 2020·Journal of Cancer Research and Clinical Oncology·Jianrong LiuJinrong Zhou
Sep 12, 2017·Annals of the New York Academy of Sciences·Do-Hee KimHye-Kyung Na
Nov 9, 2017·Molecular Medicine Reports·Shuang LiuJun Zeng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis